Synairgen PLC to present data showing drug lowers risk of long Covid symptoms

For fatigue, the relative risk reduction was 35.4%, for shortness of breath 28.3% and for loss of smell and/or taste 61.4%

Related Keywords

Leicester ,United Kingdom ,Washington ,United States ,Richard Marsden ,Chris Brightling ,University Of Leicester ,Department Of Respiratory Sciences ,Professor Chris Brightling ,Respiratory Sciences ,